Literature DB >> 3132609

Role of arachidonic acid metabolism in the mitogenic response of BALB/c 3T3 fibroblasts to epidermal growth factor.

R D Nolan1, R M Danilowicz, T E Eling.   

Abstract

We have investigated the involvement of arachidonic acid release and metabolism in the mitogenic response, i.e., [3H]thymidine incorporation, to epidermal growth factor (EGF) in BALB/c 3T3 cells. EGF induces release of arachidonate and prostaglandin (PG) formation after its addition to BALB/c 3T3 cells at the same concentrations that stimulate mitogenesis. Further, EGF-stimulated mitogenesis is blocked by inhibitors of arachidonate metabolism including indomethacin, eicosatetraynoic acid, and dexamethasone, whereas the addition of major arachidonate products in BALB/c 3T3 cells, PGE2, PGF2 alpha, and their intermediates PGG2 and PGH2, stimulate mitogenesis in synergism with EGF. The addition of PGs to BALB/c 3T3 cells also overcame indomethacin- and eicosatetraynoic acid-inhibited responses to EGF. Indomethacin must be added with EGF in order to block arachidonate metabolism and subsequent mitogenesis. These results suggest that the release of arachidonic acid and its subsequent metabolism is an apparent early requirement for the initiation of cell cycle traversal by EGF.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3132609

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  22 in total

Review 1.  Dietary fat, fatty acids and prostate cancer.

Authors:  D P Rose; J M Connolly
Journal:  Lipids       Date:  1992-10       Impact factor: 1.880

2.  Prostaglandins enhance DNA synthesis by mouse lung fibroblasts in serum-free culture.

Authors:  G M Velan; R K Kumar; R O'Grady
Journal:  In Vitro Cell Dev Biol       Date:  1991-05

3.  Rapid and transient induction of cyclo-oxygenase 2 by epidermal growth factor in human amnion-derived WISH cells.

Authors:  D J Perkins; D A Kniss
Journal:  Biochem J       Date:  1997-02-01       Impact factor: 3.857

Review 4.  Suppression of tumour development by substances derived from the diet--mechanisms and clinical implications.

Authors:  A Gescher; U Pastorino; S M Plummer; M M Manson
Journal:  Br J Clin Pharmacol       Date:  1998-01       Impact factor: 4.335

5.  On the inhibition of prostanoid formation by SK&F 96365, a blocker of receptor-operated calcium entry.

Authors:  H J Leis; D Zach; E Huber; L Ziermann; H Gleispach; W Windischhofer
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

6.  Immunocytochemical features of lens after cataract tissue--signalling molecules (growth factors, cytokines, other signalling molecules), cytoskeleton proteins, cellular and extracellular matrix proteins.

Authors:  T Shigemitsu; K Ishiguro; Y Shimizu; M Horiguchi; M Kasahara; S Arakaki
Journal:  Int Ophthalmol       Date:  1999       Impact factor: 2.031

Review 7.  Cyclooxygenase-2 modulates cellular growth and promotes tumorigenesis.

Authors:  O C Trifan; T Hla
Journal:  J Cell Mol Med       Date:  2003 Jul-Sep       Impact factor: 5.310

8.  Regulation of the nitric oxide pathway genes by tetrahydrofurandiols: microarray analysis of MCF-7 human breast cancer cells.

Authors:  Kevin Shoulars; Mary Ann Rodriguez; Trellis Thompson; John Turk; Jan Crowley; Barry M Markaverich
Journal:  Cancer Lett       Date:  2008-03-17       Impact factor: 8.679

Review 9.  Cellular proliferation and lipid metabolism: importance of lipoxygenases in modulating epidermal growth factor-dependent mitogenesis.

Authors:  T E Eling; W C Glasgow
Journal:  Cancer Metastasis Rev       Date:  1994-12       Impact factor: 9.264

10.  Immunohistochemical localization of group II phospholipase A2 in human pancreatic carcinomas.

Authors:  H Kiyohara; H Egami; H Kako; Y Shibata; K Murata; S Ohshima; K Sei; S Suko; R Kurano; M Ogawa
Journal:  Int J Pancreatol       Date:  1993-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.